Headquartered in Leiden, The Netherlands, with a US-based facility in Woburn, Massachusetts, and offices in Hong Kong, Batavia Biosciences also work with strategic partners worldwide.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze